You're viewing an archived version of this project. Please visit the new Big Give site to find current fundraising campaigns.
Impact of pneumococcal conjugate vaccine on pneumococcal disease prevalence and genetics in the UK
During 2006 a vaccine that protects against the 7 types of pneumococcal bacteria that cause most cases of severe pneumococcal disease – meningitis, septicaemia, and pneumonia – in the UK, was introduced into the routine UK infant immunisation programme. This project involves monitoring of the impact of the vaccine so we can be sure the programme is working.